Authors:
Arimori, K
Kuroki, N
Kumamoto, A
Tanoue, N
Nakano, M
Kumazawa, E
Tohgo, A
Kikuchi, M
Citation: K. Arimori et al., Excretion into gastrointestinal tract of irinotecan lactone and carboxylate forms and their pharmacodynamics in rodents, PHARM RES, 18(6), 2001, pp. 814-822
Authors:
Yamada, M
Nagatomo, J
Setoguchi, Y
Kuroki, N
Higashi, S
Setoguchi, T
Citation: M. Yamada et al., Circadian rhythms of sterol 12 alpha-hydroxylase, cholesterol 7 alpha-hydroxylase and DBP involved in rat cholesterol catabolism, BIOL CHEM, 381(12), 2000, pp. 1149-1153
Citation: S. Iritani et al., Morphological changes in neuropeptide Y-positive fiber in the hippocampal formation of schizophrenics, PROG NEUR-P, 24(2), 2000, pp. 241-249
Authors:
Kawabata, A
Kuroda, R
Kuroki, N
Nishikawa, H
Kawai, K
Araki, H
Citation: A. Kawabata et al., Characterization of the protease-activated receptor-1-mediated contractionand relaxation in the rat duodenal smooth muscle, LIFE SCI, 67(20), 2000, pp. 2521-2530
Authors:
Kawabata, A
Kuroda, R
Kuroki, N
Nishikawa, H
Kawai, K
Citation: A. Kawabata et al., Dual modulation by thrombin of the motility of rat oesophageal muscularis mucosae via two distinct protease-activated receptors (PARs): a novel role for PAR-4 as opposed to PAR-1, BR J PHARM, 131(3), 2000, pp. 578-584
Authors:
Arai, T
Ueda, K
Ikeda, K
Akiyama, H
Haga, C
Kondo, H
Kuroki, N
Niizato, K
Iritani, S
Tsuchiya, K
Citation: T. Arai et al., Argyrophilic glial inclusions in the midbrain of patients with Parkinson'sdisease and diffuse Lewy body disease are immunopositive for NACP/alpha-synuclein, NEUROSCI L, 259(2), 1999, pp. 83-86
Authors:
Iritani, S
Kuroki, N
Ikeda, K
Kazamatsuri, H
Citation: S. Iritani et al., Calbindin immunoreactivity in the hippocampal formation and neocortex of schizophrenics, PROG NEUR-P, 23(3), 1999, pp. 409-421